<DOC>
	<DOCNO>NCT00960908</DOCNO>
	<brief_summary>The objective study evaluate safety long-term effectiveness coronary stenting zotarolimus elute stent ( ZES ) determine clinical device procedural success commercial use ZES . The investigator compare 2nd generation ZE ( Endeavor resolute , active prospective arm ) 1st generation ZES ( Endeavor Sprint , retrospective arm ) .</brief_summary>
	<brief_title>Registry Evaluate Efficacy Zotarolimus-Eluting Stent</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>The patient agree participate study sign informed consent form . Alternatively , legally authorize patient representative may agree patient 's participation study sign inform consent form . There exclusion criterion registry .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Zotarolimus</keyword>
	<keyword>Drug elute stent</keyword>
	<keyword>Endeavor Resolute</keyword>
</DOC>